Abstract
A new protease, named SsMTP was identified from the archeon Sulfolobus solfataricus. The enzyme is associated to the cell-membrane and over-produced in response to the peptide-enriched media. SsMTP has a molecular mass of 120 kDa showing optimal activity at pH 2.0 in the temperature range 70 - 90 °C, and a half-life of 20 days at 80 °C. Primary structure analysis revealed that SsMTP represents a novel type of multi-domain thermopsin-like protease containing the catalytic domain followed by two distinct domains, PKD and Y_Y_Y, which are usually involved in a range of protein- protein interactions among the extracellular proteins.
Keywords: Sulfolobus solfataricus, Membrane-bound extracellular protease, Thermopsin-like protease, Multi-domain protease
Protein & Peptide Letters
Title: Identification of a Cell-Bound Extracellular Protease Overproduced by Sulfolobus solfataricus in Peptide-Rich Media
Volume: 17 Issue: 1
Author(s): Raffaele Cannio, Giuliana Catara, Imma Fiume, Marco Balestrieri, Mose Rossi and Gianna Palmieri
Affiliation:
Keywords: Sulfolobus solfataricus, Membrane-bound extracellular protease, Thermopsin-like protease, Multi-domain protease
Abstract: A new protease, named SsMTP was identified from the archeon Sulfolobus solfataricus. The enzyme is associated to the cell-membrane and over-produced in response to the peptide-enriched media. SsMTP has a molecular mass of 120 kDa showing optimal activity at pH 2.0 in the temperature range 70 - 90 °C, and a half-life of 20 days at 80 °C. Primary structure analysis revealed that SsMTP represents a novel type of multi-domain thermopsin-like protease containing the catalytic domain followed by two distinct domains, PKD and Y_Y_Y, which are usually involved in a range of protein- protein interactions among the extracellular proteins.
Export Options
About this article
Cite this article as:
Cannio Raffaele, Catara Giuliana, Fiume Imma, Balestrieri Marco, Rossi Mose and Palmieri Gianna, Identification of a Cell-Bound Extracellular Protease Overproduced by Sulfolobus solfataricus in Peptide-Rich Media, Protein & Peptide Letters 2010; 17 (1) . https://dx.doi.org/10.2174/092986610789909458
DOI https://dx.doi.org/10.2174/092986610789909458 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry Erectile Dysfunction and Coronary Artery Disease in Patients with Diabetes
Current Diabetes Reviews The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease
Mini-Reviews in Medicinal Chemistry Barriers to Achieving Optimal Glycemic Control in a Multi-Ethnic Society: A US Focus
Current Diabetes Reviews Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
Endocrine, Metabolic & Immune Disorders - Drug Targets Peripheral Blood Derived Cell Trafficking for Cardiac Regeneration
Current Stem Cell Research & Therapy Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Current Pharmaceutical Design Editorial: Cardiovascular Disease Mortality Rates are Plateauing in Certain Age Groups and Regions. Can we Keep them Declining?
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Genomics Peptidomimetics and their Applications in Antifungal Drug Design
Anti-Infective Agents in Medicinal Chemistry Chalcones: Retrospective Synthetic Approaches and Mechanistic Aspects of a Privileged Scaffold
Current Pharmaceutical Design Silk Fibroin Based Drug Delivery Applications: Promises and Challenges
Current Drug Targets HDL - Cholesterol: The New Target for Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Metabolic Syndrome and Adipose Tissue: New Clinical Aspects and Therapeutic Targets
Current Pharmaceutical Design A Nested Case-Control Study of Serum Fasting Lipid Profiles in Pre- Eclamptic Primigravidas in Ile-Ife, Nigeria
Current Hypertension Reviews Isoform-Selective PI3K Inhibitors for Various Diseases
Current Topics in Medicinal Chemistry Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Mini-Reviews in Medicinal Chemistry Pathophysiology and Treatment of Obesity Hypertension
Current Pharmaceutical Design Gene Therapy for Immunologic Tolerance: Using Bone Marrow-Derived Cells to Treat Autoimmunity and Hemophilia
Current Stem Cell Research & Therapy A Method for the Micro-encapsulation of Dielectric Fluids in Joined Polymer Shells
Current Organic Chemistry